ADAndrew J. Duncan

Andrew J. Duncan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Andrew J. Duncan has a total of 125 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Characterising executive functioning in the chronic phase of autoimmune encephalitis: A study by the Australian autoimmune encephalitis consortium

    by Katherine Y. Ko, Nabil Seery, Sarah Griffith, Christina Kazzi, Robb Wesselingh, Tiffany Rushen, Tracie H. Tan, Hannah Ford, Catherine Meade, Marie F. O'SHea, et al.

  • Open Access

    Acute and Long-Term Immune-Treatment Strategies in Anti-LGI1 Antibody–Mediated Encephalitis

    by Nabil Seery, Robb Wesselingh, Paul Beech, Laurie M. McLaughlin, Tiffany Rushen, Amy J. Halliday, Liora ter Horst, Sarah P. Griffith, Mirasol Forcadela, Tracie H. Tan, et al.

    Few studies have evaluated acute immunotherapy and relapse prevention strategies in patients with anti-leucine-rich glioma-inactivated 1 (LGI1) antibody (Ab)-mediated encephalitis. The objective of this study was to analyze the outcomes of acute and long-term immunotherapy strategies in this population. We undertook a multicenter cohort study of 55 patients with anti-LGI1 Ab-mediated encephalitis, either recruited prospectively or identified retrospectively from 10 Australian hospitals as part of the Australian Autoimmune Encephalitis Consortium. Clinical data were collected, including treatment durations of all relevant immunotherapies. Clinical outcomes that we examined included (1) time to first clinical relapse, (2) improvement on modified Rankin Scale (mRS), and (3) favorable binary composite clinical-functional outcome at 12 months. A favorable outcome was defined as fulfilling all three of mRS less than 3, a score of 1 or less in the memory dysfunction component of the Clinical Assessment Scale in Autoimmune Encephalitis, and absence of drug-resistant epilepsy. Rituximab, adjusted for concomitant use of other immunotherapies, was associated with increased time to first relapse (hazard ratio 0.10; 95% CI 0.001-0.85; p = 0.03). Intravenous pulsed methylprednisolone was associated with an improvement in mRS (OR 4.48; 95% CI 1.03-21.3; p = 0.048) and a favorable composite clinical-functional outcome (OR 4.96; 95% CI 1.07-27.2; p = 0.049) at 12 months. Rituximab may be effective at preventing relapses in patients with anti-LGI1 Ab-mediated encephalitis. Acute methylprednisolone treatment may be associated with favorable outcomes at 12 months. This study provides Class IV evidence that for patients with anti-LGI1 Ab-mediated encephalitis, rituximab prevents relapses and acute methylprednisolone is associated with favorable outcomes at 12 months.


  • Open Access

    Expanding Accurate Person Recognition to New Altitudes and Ranges: The BRIAR Dataset

    by David Cornett Iii, Joel Brogan, Nell Barber, Deniz Aykac, Seth Baird, Nick Burchfield, Carl Dukes, Andrew Duncan, Regina Ferrell, Jim Goddard, et al.

    Face recognition technology has advanced significantly in recent years due largely to the availability of large and increasingly complex training datasets for use in deep learning models. These datasets, however, typically comprise images scraped from news sites or social media platforms and, therefore, have limited utility in more advanced security, forensics, and military applications. These applications require lower resolution, longer ranges, and elevated viewpoints. To meet these critical needs, we collected and curated the first and second subsets of a large multi-modal biometric dataset designed for use in the research and development (R&D) of biometric recognition technologies under extremely challenging conditions. Thus far, the dataset includes more than 350,000 still images and over 1,300 hours of video footage of approximately 1,000 subjects. To collect this data, we used Nikon DSLR cameras, a variety of commercial surveillance cameras, specialized long-rage R&D cameras, and Group 1 and Group 2 UAV platforms. The goal is to support the development of algorithms capable of accurately recognizing people at ranges up to 1,000 m and from high angles of elevation. These advances will include improvements to the state of the art in face recognition and will support new research in the area of whole-body recognition using methods based on gait and anthropometry. This paper describes methods used to collect and curate the dataset, and the dataset's characteristics at the current stage.

  • Open Access

    Federated Bayesian Computation via Piecewise Deterministic Markov Processes

    by Joris Bierkens, Andrew Duncan

    When performing Bayesian computations in practice, one is often faced with the challenge that the constituent model components and/or the data are only available in a distributed fashion, e.g. due to privacy concerns or sheer volume. While various methods have been proposed for performing posterior inference in such federated settings, these either make very strong assumptions on the data and/or model or otherwise introduce significant bias when the local posteriors are combined to form an approximation of the target posterior. By leveraging recently developed methods for Markov Chain Monte Carlo (MCMC) based on Piecewise Deterministic Markov Processes (PDMPs), we develop a computation -- and communication -- efficient family of posterior inference algorithms (Fed-PDMC) which provides asymptotically exact approximations of the full posterior over a large class of Bayesian models, allowing heterogenous model and data contributions from each client. We show that communication between clients and the server preserves the privacy of the individual data sources by establishing differential privacy guarantees. We quantify the performance of Fed-PDMC over a class of illustrative analytical case-studies and demonstrate its efficacy on a number of synthetic examples along with realistic Bayesian computation benchmarks.

  • Predictive semiology of psychogenic non-epileptic seizures in an epilepsy monitoring unit

    by Andrew J. Duncan, Ivana Peric, Ray Boston, Udaya Seneviratne

    Introduction The diagnosis of psychogenic nonepileptic seizures (PNES) is a common clinical dilemma. We sought to assess the diagnostic value of four ictal signs commonly used in differentiating PNES from epileptic seizures (ES). Methods We retrospectively reviewed consecutive adult video-electroencephalogram (VEM) studies conducted at a single tertiary epilepsy center between May 2009 and August 2016. Each event was assessed by a blinded rater for the presence of four signs: fluctuating course, head shaking, hip thrusting, and back arching. The final diagnosis of PNES or ES was established for each event based on clinical and VEM characteristics. All ES were pooled regardless of focal or generalized onset. We analyzed the odds ratio of each sign in PNES in comparison to ES with adjustment for repeated measures using logistic regression. Additionally, we calculated the sensitivity, specificity, predictive values, and likelihood ratios of each sign to diagnose PNES. Results A total of 742 events from 140 VEM studies were assessed. Fluctuating course (odds ratio (OR) 37.37, 95% confidence interval (CI) 13.56–102.96, P < 0.0001), head shaking (OR 2.95, 95% CI 1.26–6.79, P = 0.012), and hip thrusting (OR 4.28, 95% CI 1.21–15.18, P = 0.02) were each significantly predictive of PNES. Fluctuating course had the highest sensitivity (76.16%). Back arching (OR 1.06, 95% CI 0.35–3.20, P = 0.92) was not significantly associated with PNES. Conclusion Fluctuating course, head shaking, and hip thrusting are semiological features significantly more common in PNES than ES. Fluctuating course is the most reliable sign. Back arching does not appear to differentiate PNES from ES.


  • Mutations in SNX14 Cause a Distinctive Autosomal-Recessive Cerebellar Ataxia and Intellectual Disability Syndrome

    by Anna C. Thomas, Hywel Williams, Núria Setó-Salvia, Chiara Bacchelli, Dagan Jenkins, Mary O’sUllivan, Konstantinos Mengrelis, Miho Ishida, Louise Ocaka, Estelle Chanudet, et al.